Suppr超能文献

HLA-DR 标记活动性结核患者中最近分化的抗原特异性效应性 CD4 T 细胞。

HLA-DR Marks Recently Divided Antigen-Specific Effector CD4 T Cells in Active Tuberculosis Patients.

机构信息

Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA.

Faculty of Medicine, General Sir John Kotelawala Defense University, Ratmalana, Sri Lanka.

出版信息

J Immunol. 2021 Jul 15;207(2):523-533. doi: 10.4049/jimmunol.2100011. Epub 2021 Jun 30.

Abstract

Upon Ag encounter, T cells can rapidly divide and form an effector population, which plays an important role in fighting acute infections. In humans, little is known about the molecular markers that distinguish such effector cells from other T cell populations. To address this, we investigated the molecular profile of T cells present in individuals with active tuberculosis (ATB), where we expect Ag encounter and expansion of effector cells to occur at higher frequency in contrast to -sensitized healthy IGRA individuals. We found that the frequency of HLA-DR cells was increased in circulating CD4 T cells of ATB patients, and was dominantly expressed in Ag-specific CD4 T cells. We tested and confirmed that HLA-DR is a marker of recently divided CD4 T cells upon Ag exposure using an in vitro model examining the response of resting memory T cells from healthy IGRA to Ags. Thus, HLA-DR marks a CD4 T cell population that can be directly detected ex vivo in human peripheral blood, whose frequency is increased during ATB disease and contains recently divided Ag-specific effector T cells. These findings will facilitate the monitoring and study of disease-specific effector T cell responses in the context of ATB and other infections.

摘要

当遇到抗原时,T 细胞可以迅速分裂并形成效应细胞群体,这在对抗急性感染中起着重要作用。在人类中,对于区分这种效应细胞与其他 T 细胞群体的分子标记知之甚少。为了解决这个问题,我们研究了活跃性肺结核(ATB)个体中存在的 T 细胞的分子特征,我们预计在这些个体中,抗原接触和效应细胞的扩增会更频繁地发生,与致敏的健康 IGRA 个体相比。我们发现,循环 CD4 T 细胞中 HLA-DR 细胞的频率在 ATB 患者中增加,并且主要在 Ag 特异性 CD4 T 细胞中表达。我们使用体外模型检测了健康 IGRA 个体的静止记忆 T 细胞对 Ag 的反应,测试并证实 HLA-DR 是 Ag 暴露后新近分裂的 CD4 T 细胞的标志物。因此,HLA-DR 标记了一个可以在人类外周血中直接检测到的 CD4 T 细胞群体,其在 ATB 疾病期间增加,并包含最近分裂的 Ag 特异性效应 T 细胞。这些发现将有助于监测和研究 ATB 及其他感染情况下的疾病特异性效应 T 细胞反应。

相似文献

1
HLA-DR Marks Recently Divided Antigen-Specific Effector CD4 T Cells in Active Tuberculosis Patients.
J Immunol. 2021 Jul 15;207(2):523-533. doi: 10.4049/jimmunol.2100011. Epub 2021 Jun 30.
4
Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
J Clin Invest. 2015 May;125(5):1827-38. doi: 10.1172/JCI77990. Epub 2015 Mar 30.
8
Diagnostic Value of CD25, CD69, and CD134 on Tuberculosis-Specific Antigen-Stimulated CD4+ T Cells for Tuberculous Pleurisy.
J Immunol Res. 2023 Sep 27;2023:5309816. doi: 10.1155/2023/5309816. eCollection 2023.

引用本文的文献

1
Minimal immune cell subset differences in a cohort of close contacts of tuberculosis index cases.
bioRxiv. 2025 Aug 4:2025.08.04.668387. doi: 10.1101/2025.08.04.668387.
6
EPA Induces an Anti-Inflammatory Transcriptome in T Cells, Implicating a Triglyceride-Independent Pathway in Cardiovascular Risk Reduction.
JACC Basic Transl Sci. 2025 Mar;10(3):383-395. doi: 10.1016/j.jacbts.2024.09.002. Epub 2024 Oct 30.
8
Impaired -specific T-cell memory phenotypes and functional profiles among adults with type 2 diabetes mellitus in Uganda.
Front Immunol. 2024 Oct 4;15:1480739. doi: 10.3389/fimmu.2024.1480739. eCollection 2024.
9
Increased Activation Markers of Adaptive Immunity in Patients with Severe COVID-19.
J Clin Med. 2024 Sep 24;13(19):5664. doi: 10.3390/jcm13195664.
10
Sodium chloride in the tumor microenvironment enhances T cell metabolic fitness and cytotoxicity.
Nat Immunol. 2024 Oct;25(10):1830-1844. doi: 10.1038/s41590-024-01918-6. Epub 2024 Aug 28.

本文引用的文献

1
Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4 T Cells in COVID-19.
Cell. 2020 Nov 25;183(5):1340-1353.e16. doi: 10.1016/j.cell.2020.10.001. Epub 2020 Oct 5.
2
Disease extent and anti-tubercular treatment response correlates with -specific CD4 T-cell phenotype regardless of HIV-1 status.
Clin Transl Immunology. 2020 Sep 28;9(9):e1176. doi: 10.1002/cti2.1176. eCollection 2020.
3
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.
Nature. 2020 Nov;587(7833):270-274. doi: 10.1038/s41586-020-2598-9. Epub 2020 Jul 29.
5
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.
Science. 2020 Sep 4;369(6508). doi: 10.1126/science.abc8511. Epub 2020 Jul 15.
6
Comprehensive mapping of immune perturbations associated with severe COVID-19.
Sci Immunol. 2020 Jul 15;5(49). doi: 10.1126/sciimmunol.abd7114.
7
The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
JCI Insight. 2020 May 21;5(10):137799. doi: 10.1172/jci.insight.137799.
9
Cutting Edge: Characterization of Human Tissue-Resident Memory T Cells at Different Infection Sites in Patients with Tuberculosis.
J Immunol. 2020 May 1;204(9):2331-2336. doi: 10.4049/jimmunol.1901326. Epub 2020 Mar 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验